Long term treatment of polymyalgia rheumatica with deflazacort (Q33566338)

28 July 2017

title

Long term treatment of polymyalgia rheumatica with deflazacort (English)

1 reference

28 July 2017

main subject

polymyalgia rheumatica

1 reference

Cimmino MA

1

1 reference

28 July 2017

Moggiana G

2

1 reference

28 July 2017

Montecucco C

3

1 reference

28 July 2017

Caporali R

4

1 reference

28 July 2017

Accardo S

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

53

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

331-333

1 reference

Prognosis and management of polymyalgia rheumatica

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Polymyalgia rheumatica and corticosteroids: how much for how long?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

A seasonal pattern in the onset of polymyalgia rheumatica

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005333

Polymyalgia rheumatica. Duration of therapy and long-term outcome

31 October 2018

1 reference

12 December 2020

Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics

1 reference

12 December 2020

Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica

1 reference

12 December 2020

Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis

1 reference

12 December 2020

A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.53.5.331

1 reference

28 July 2017

1 reference

28 July 2017

1 reference